GHRH
Compounds       thought to inhibit hypothalamic somatostatin (SRIH) release (pyridostigmine,       arginine, galanin, atenolol) consistently improve, though do not normalize, the       somatotropin response to GHRH in obesity.
Compounds       thought to inhibit hypothalamic somatostatin (SRIH) release (pyridostigmine,       arginine, galanin, atenolol) consistently improve, though do not normalize, the       somatotropin response to  @SUBJECT$   @PREDICAT$   @OBJECT$ .